CGEN vs MCRB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 14, 2026

CGEN

47.9
AI Score
VS
CGEN Wins

MCRB

36.9
AI Score

Investment Advisor Scores

CGEN

48score
Recommendation
HOLD

MCRB

37score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CGEN MCRB Winner
Revenue 72.76M 7.13M CGEN
Net Income 35.34M -250.16M CGEN
Net Margin 48.6% -3509.5% CGEN
Operating Income 31.33M -179.91M CGEN
ROE 34.4% -2319.9% CGEN
ROA 22.6% -71.7% CGEN
Total Assets 156.57M 348.78M MCRB
Cash 90.60M 163.03M MCRB
Current Ratio 6.56 2.28 CGEN
Free Cash Flow 31.33M -238.64M CGEN

Relative Price Performance (Last 90 Days)

CGEN 1M: +11.8% · 3M: +0.2% MCRB 1M: -12.8% · 3M: -43.4%

Current Technical Phase

CGEN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 62

RSI (14): 62.0 · Price: $2.62

MCRB

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.4%), weak momentum, RSI 39

RSI (14): 39.5 · Price: $4.56

Fundamentals Snapshot

Metric CGEN MCRB
Market Cap
Forward P/E -7.1 -0.9
Trailing P/E 7.0
Revenue (TTM)
Revenue Growth 1.1% -0.9%
Gross Margin 0.9% -24.5%
Operating Margin -3.4% -21.0%
EPS 0.38 -2.36
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CGEN is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.